artenimol has been researched along with cyclin d1 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Jiang, H; Pan, S; Sun, B; Sun, X | 1 |
| Li, J; Liao, K; Wang, Z | 1 |
| Fan, HN; Peng, SQ; Qu, GQ; Zhang, J; Zhu, JS; Zhu, MY | 1 |
3 other study(ies) available for artenimol and cyclin d1
| Article | Year |
|---|---|
Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Artemisinins; bcl-2-Associated X Protein; Caspase 9; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Humans; Ki-67 Antigen; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-bcl-2; Xenograft Model Antitumor Assays | 2009 |
Dihydroartemisinin inhibits cell proliferation via AKT/GSK3β/cyclinD1 pathway and induces apoptosis in A549 lung cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Artemisinins; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Flow Cytometry; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Immunohistochemistry; Lung Neoplasms; Proto-Oncogene Proteins c-akt; Real-Time Polymerase Chain Reaction; Signal Transduction | 2014 |
Dihydroartemisinin inhibits the growth and invasion of gastric cancer cells by regulating cyclin D1-CDK4-Rb signaling.
Topics: Animals; Artemisinins; Carcinogenesis; Cell Cycle Checkpoints; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase 4; Female; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Neoplasm Invasiveness; Prognosis; Signal Transduction; Stomach; Stomach Neoplasms; Xenograft Model Antitumor Assays | 2020 |